ArticleInternational journal of clinical oncology2025

Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan.

Yusa Togashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.